Levodopa: A novel therapeutic prospect for liver disease

doi:10.4254/wjh.v18.i2.115563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

This Article

(30)

(43)

(0)

(674)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Hepatol. Feb 27, 2026; 18(2): 115563
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.115563

Full Size Figure Download Figure

Figure 1 The schematic illustration of the putative mechanisms underlying levodopa-mediated therapeutic effects in liver disease. DRD1: Dopamine receptor D1; YAP1: Yes-associated protein 1.

Citation: Xu J, Qian Y, Wang JM, Wu XL, Zheng YY. Levodopa: A novel therapeutic prospect for liver disease. World J Hepatol 2026; 18(2): 115563
URL: https://www.wjgnet.com/1948-5182/full/v18/i2/115563.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i2.115563

Xu J, Qian Y, Wang JM, Wu XL, Zheng YY. Levodopa: A novel therapeutic prospect for liver disease. World J Hepatol 2026; 18(2): 115563 [PMID: 41809467 DOI: 10.4254/wjh.v18.i2.115563]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.